2016
DOI: 10.1016/j.intimp.2015.11.024
|View full text |Cite
|
Sign up to set email alerts
|

Fingolimod ameliorates the development of experimental autoimmune encephalomyelitis by inhibiting Akt–mTOR axis in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
16
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(21 citation statements)
references
References 38 publications
4
16
0
Order By: Relevance
“…Regarding its detailed mechanisms, other studies have discovered that FTY720 can promote PP2A phosphatase activities in many types of cells [30][31][32] and dephosphorylate activated signal transducer and activator of transcription-1 (STAT-3) [33,34] and AKT [35,36]. In our study, FTY720 reduced a-SMA and collagen expression, suggesting that FTY720 prevents the genesis of myofibroblasts and reduces the synthesis of ECM protein in vivo.…”
Section: Discussionsupporting
confidence: 54%
“…Regarding its detailed mechanisms, other studies have discovered that FTY720 can promote PP2A phosphatase activities in many types of cells [30][31][32] and dephosphorylate activated signal transducer and activator of transcription-1 (STAT-3) [33,34] and AKT [35,36]. In our study, FTY720 reduced a-SMA and collagen expression, suggesting that FTY720 prevents the genesis of myofibroblasts and reduces the synthesis of ECM protein in vivo.…”
Section: Discussionsupporting
confidence: 54%
“…The main finding in our study is the observation that cells from EAE + Art mice presented lower expression of chemokine receptors, reduced migratory ability, and did not leave the secondary lymphoid organs in the course of EAE. Similar results are found in mice and transplanted/MS patients treated with FTY720 (fingolimod) and FK506 (tacrolimus) [46][47][48][49][50][51]. In our study, we found that T cells maintained their encephalitogenic potential after Art treatment, as transfer of cells from EAE + Art mice to RAG2 À/À mice resulted in normal disease development.…”
Section: Discussionsupporting
confidence: 88%
“…In a pattern different to that of IL‐10, mRNA levels for TGFB, already low in CIS individuals, were lower again in PBMCs from MS patients. Low levels of expression of tolerance‐inducing TGFB have been reported in experimental autoimmune encephalomyelitis, the murine model of neuroinflammation used to study MS, with increased expression after treatment with the disease modifier, fingolimod 23. Also, in PBMCs from patients with established disease, TNF mRNA levels are higher and IL‐10 and TGFB levels are lower during relapse, and this balance is inverted during stable disease 24…”
Section: Discussionmentioning
confidence: 99%